QIAGEN Acquires Verogen
January 9, 2023
QIAGEN completed the acquisition of Verogen for $150 million in cash, bringing Verogen’s NGS-based human identification and forensic genomics products and the GEDmatch database into QIAGEN’s forensics portfolio. The deal gives QIAGEN exclusive distribution rights for the MiSeq FGx forensic sequencer version and is intended to expand QIAGEN’s capabilities and commercial footprint in the fast-growing Human ID/forensics market.
- Buyers
- QIAGEN
- Targets
- Verogen
- Industry
- Biotechnology
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.